[ad_1]
Covid vaccine sales are expected to remain substantial for both companies this year and account for virtually all their revenue.
Courtesy Moderna
Companies with a lot of cash offer a great security blanket for investors—and Covid vaccine makers
BioNTech
and
Moderna
are two of the most cash-rich large companies in the world relative to their size.
[ad_2]
Source link
